Search results
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market By Investing.com
Investing.com· 7 days agoVerona Pharma (NASDAQ:VRNA) has announced its first quarter 2024 financial results, highlighting the...
Olympus Highlighting COPD Treatment, AI-Driven Screening Process and EVIS X1 Bronchoscopes at...
WJTV Jackson· 1 day agoSeleCT™ Screening, an algorithm-driven screening process, reviews existing chest CT scans to help identify patients who would benefit from bronchoscopic lung volume reduction ...
Chiesi to Present New Data Showcasing Depth of Respiratory Leadership at the American Thoracic...
GlobeNewswire via Yahoo Finance· 11 hours agoPresentations will highlight new data in respiratory conditions, including asthma and chronic...
Patients Fare Better When They Get Palliative Care Sooner, Not Later
Scientific American· 2 days agoIn the last months of my mother’s life, before she went into hospice, she was seen at home by a...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 3 days agoThese products have the potential to address the needs of millions of patients both in France and...
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 12 hours agoLast year, Regeneron earned approval for a high-dose formulation of the medicine that requires fewer...
The Assistance Fund Opens New Program for Chronic Obstructive Pulmonary Disease
Digital Journal· 3 days agoThe program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles. Chronic obstructive ...
NHS nurses create device to save lung patients and CF sufferers' lives
Daily Express· 2 days agoInspired NHS nurses have created a device that not only helps save lung patients' lives, but also...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 3 days agoDupixent was first approved in 2017 for the treatment of atopic dermatitis, also known as eczema....
Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial
Guru Focus· 6 days agoThe biopharmaceutical company, which focuses on developing treatments for respiratory diseases, reported a net loss and detailed its strategic preparations for the anticipated ...